These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 909051)

  • 41. Cimetidine: a specific inhibitor of hepatic aryl hydrocarbon hydroxylase (AHH) in the rat.
    Drew R; Rowell J; Grygiel JJ
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):81-93. PubMed ID: 7268211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of benzonal on the liver mono-oxygenase system of laboratory animals].
    Savateev NV; Liniuchev MN; Sergeev VV; Panov BP; Ovsiannikova LM
    Farmakol Toksikol; 1985; 48(2):100-3. PubMed ID: 2987026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of metyrapone on liver microsomal drug oxidations.
    Leibman KC
    Mol Pharmacol; 1969 Jan; 5(1):1-9. PubMed ID: 4392111
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of inducers of liver microsomal enzymes on the composition of microsomal hemoprotein.
    Kuntzman R; Alvares AP; Levin W
    Adv Cytopharmacol; 1971 May; 1():241-7. PubMed ID: 5163245
    [No Abstract]   [Full Text] [Related]  

  • 45. In-vivo and in-vitro studies of the effects of mercaptoundecahydrododecaborate (BSH) on hepatic cytochrome P-450 mono-oxygenase enzyme activity and on hexobarbital (HXB) induced sleep in mice.
    Fontenelle L; Garner G; Graham B; Goettsch R; Soltani B
    Strahlenther Onkol; 1989; 165(2-3):172-3. PubMed ID: 2928942
    [No Abstract]   [Full Text] [Related]  

  • 46. A survey of the response of different strains of mice to substances metabolised by microsomal oxidation; hexobarbitone, zoxazolamine and warfarin.
    Lush IE
    Chem Biol Interact; 1976 Mar; 12(3-4):363-73. PubMed ID: 1253337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of mixed function oxidases in rat liver by trans- and cis-1,2-dichloroethylene.
    Freundt KJ; Macholz J
    Toxicology; 1978 Jun; 10(2):131-9. PubMed ID: 684758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A study of the interaction of a series of substituted barbituric acids with the hepatic microsomal monooxygenase.
    Jansson I; Orrenius S; Ernster L; Schenkman JB
    Arch Biochem Biophys; 1972 Aug; 151(2):391-400. PubMed ID: 4402992
    [No Abstract]   [Full Text] [Related]  

  • 49. [Stimulation of drug oxidation in kidney microsomes by phenobarbital].
    Uehleke H; Greim H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 261(2):152-61. PubMed ID: 4235047
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of hypophysectomy and cyproterone acetate on the liver ultrastructure as well as on hexobarbital anesthesia and zoxazolamine paralysis in rats.
    Szabo S; Kovacs K; Garg BD; Tuchweber B; Lazar G
    Horm Metab Res; 1973 Mar; 5(2):109-13. PubMed ID: 4707694
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of thiamine consumption on liver microsomal drug-metabolizing pathways.
    Grosse W; Wade AE
    J Pharmacol Exp Ther; 1971 Mar; 176(3):758-65. PubMed ID: 4398746
    [No Abstract]   [Full Text] [Related]  

  • 52. [The effect of sandimmun on the activity of mixed-function mono-oxidases in the liver microsomes].
    Astashkin EI; Prikhod'ko AZ
    Eksp Klin Farmakol; 1994; 57(6):40-2. PubMed ID: 7756960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction by phenobarbital of hepatic microsomal drug-metabolizing enzyme system in partially hepatectomized rats.
    Hino Y; Imai Y; Sato R
    J Biochem; 1974 Oct; 76(4):735-44. PubMed ID: 4436286
    [No Abstract]   [Full Text] [Related]  

  • 54. Changes in Michaelis and spectral constants for aniline in hepatic microsomes from phenobarbital-treated rats.
    Guarino AM; Gram TE; Gigon PL; Greene FE; Gillette JR
    Mol Pharmacol; 1969 Mar; 5(2):131-6. PubMed ID: 5787083
    [No Abstract]   [Full Text] [Related]  

  • 55. KINETICS OF DRUG METABOLISM BY HEPATIC MICROSOMES.
    RUBIN A; TEPHLY TR; MANNERING GJ
    Biochem Pharmacol; 1964 Jul; 13():1007-16. PubMed ID: 14201123
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of phenobarbital pretreatment on the response of rat liver to halothane administration.
    Stenger RJ; Johnson EA
    Proc Soc Exp Biol Med; 1972 Sep; 140(4):1319-24. PubMed ID: 5057597
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of ethynyl estradiol on liver microsomal mixed function oxygenase activity in male rats.
    Sweeney GD; Cole FM
    Lab Invest; 1980 Feb; 42(2):231-5. PubMed ID: 7354619
    [No Abstract]   [Full Text] [Related]  

  • 58. [The correction of the liver detoxifying function with phenobarbital and ziksorin before and after ischemia].
    Grek OR; Rybakova TA; Sharapov VI; Zakharova MV; Shkurupiĭ VA
    Eksp Klin Farmakol; 1993; 56(5):30-3. PubMed ID: 8312805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Temporal course of the induction of delta aminolevulinic acid synthetase, hexobarbital decorporating enzyme and cytochrome P450 in the rat liver following phenobarbital administration].
    Held H; von Oldershausen HF
    Klin Wochenschr; 1969 Nov; 47(22):1234-5. PubMed ID: 5382018
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect on newborn rats of perinatal exposure to phenobarbital.
    Mitoma C; LeValley SE
    Arch Int Pharmacodyn Ther; 1970 Sep; 187(1):155-62. PubMed ID: 5480135
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.